Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | PAM | P19021 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | CES2 | O00748 | 3/20 | 0.48 |
| ▸ | CES1 | P23141 | 3/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 4/20 | 0.47 |
| ▸ | PPARG | P37231 | 5/20 | 0.46 |
| ▸ | PPARD | Q03181 | 5/20 | 0.46 |
| ▸ | PPARA | Q07869 | 5/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TLR2 | O60603 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6689556 | 1.00 | DGKA (0.55) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL3762292 | 1.00 | DGKA (0.55) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL339526 | 1.00 | DGKA (0.55) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL6688849 | 1.00 | DGKA (0.55) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL3846923 | 1.00 | DGKA (0.55) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL1827580 | 1.00 | DGKA (0.55) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL5431993 | 1.00 | DGKA (0.55) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL1445754 | 1.00 | DGKA (0.55) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL1593662 | 1.00 | DGKA (0.55) | DGKALMNAPAMMAPTMAPK1 | |
| Octane SCHEMBL27910076 | 1.00 | DGKA (0.55) | DGKALMNAPAMMAPTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119278054-A | Glycosylated prodrugs | 莱顿大学 | 2025-01-07 | — | — | CN | disclosed |
| CN-119012999-A | Improved nasal administration of pharmaceutical formulations | 思瑞诺医疗有限公司 | 2024-11-22 | — | — | CN | disclosed |
| WO-2023183285-A1 | METHODS OF DIAGNOSING AND TREATING NEURODEGENERATIVE DISEASES | THE GENERAL HOSPITAL CORPORATION (US) | 2023-09-28 | — | — | WO | disclosed |
| CN-115844903-A | Application of betulin derivative in preparation of bacteria inhibiting medicine | 潍坊赛宝工业技术研究院有限公司 | 2023-03-28 | — | — | CN | disclosed |
| CN-114206396-A | Methods and compositions for attenuating an immune response against an antiviral transfer vector | 西莱克塔生物科技公司 | 2022-03-18 | — | — | CN | disclosed |
| EP-3755697-A1 | DEGRADERS OF EGFR AND METHODS OF USE THEREOF | Dana Farber Cancer Institute, Inc. (US) | 2020-12-30 | — | — | EP | disclosed |
| WO-2019164953-A1 | DEGRADERS OF EGFR AND METHODS OF USE THEREOF | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2019-08-29 | — | — | WO | disclosed |
| US-20110218343-A1 | SMALL MOLECULE INHIBITORS OF ROTAMASE ENZYME ACTIVITY | GLIAMED, INC. (US) | 2011-09-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110218343-A1 | SMALL MOLECULE INHIBITORS OF ROTAMASE ENZYME ACTIVITY | FKBP8, FKBP1A, FKBP2 | DGKA 4183/4885LMNA 4868/4885PAM 4806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.